BY OUR BUSINESS CORRESPONDENT The Indian equity market displayed remarkable resilience on Friday, shrugging off weak global cues to post significant gains. Key benchmark indices climbed as investor focus shifted…
By Our Business Bureau Indian equity benchmarks finished a lacklustre session on Thursday, surrendering most of their early gains as investors adopted a cautious stance amid escalating geopolitical tensions in…
By Our Business Correspondent Domestic equity markets ended with modest gains on Wednesday after surrendering a large part of their intraday rally as investors booked profits amid mounting geopolitical concerns…
Our Correspondent Domestic equity benchmarks witnessed a sharp correction on Tuesday, extending the losing streak to three consecutive sessions as a cocktail of rising crude oil prices, escalating Middle East…
AMN / BIZ DESK Domestic equity benchmarks staged a resilient recovery on Monday, shaking off early morning jitters to close marginally higher. Despite escalating geopolitical tensions in the Middle East…
After four consecutive months of selling, Foreign Portfolio Investors (FPIs) have turned net buyers of Indian equities. According to the latest depository data, FPIs have invested 15 thousand 157 crore…
STAFF REPORTER The National Stock Exchange of India (NSE) has announced a record-breaking performance for its Crude Oil Options, with the segment achieving its highest-ever daily premium turnover of ₹2,006.49…
By Our Business Correspondent Benchmark equity indices concluded a robust trading week with a sharp rally on Friday, as investor confidence strengthened on the back of positive quarterly earnings and…
Sensex Gains 238 Points, Nifty Settles Above 23,950 By Our Business Correspondent Domestic benchmark indices staged a recovery on Thursday, snapping a two-session losing streak. The market was buoyed by…
NEWS DESK Dr Reddy’s shares tumbled 7% as quality issue delays commercial launch of semaglutide- Dr Reddy’s Laboratories said on Thursday that it is delaying commercial supplies of semaglutide due…
